Neoadjuvant chemotherapy with a combination of docetaxel, cisplatin, fluorouracil, and leucovorin in nonresectable advanced gastric cancer: a short communication

被引：2
作者：
Ma, Yanlei [1 ]
Qin, Huanlong [1 ]
Zheng, Qi [1 ]
Wang, Yu [1 ]
Wang, Zhiguo [1 ]
Yang, Zhe [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Peoples Hosp Affiliated 6, Dept Surg, Shanghai 200233, Peoples R China
来源：
MEDICAL ONCOLOGY | 2010年 / 27卷 / 04期
关键词：
Neoadjuvant chemotherapy; Nonresectable advanced gastric cancer; Docetaxel; Cisplatin; Fluorouracil; Leucovorin; PHASE-II; PLUS FLUOROURACIL; RANDOMIZED-TRIAL; 1ST-LINE THERAPY; D2; GASTRECTOMY; CARCINOMA; ADENOCARCINOMA; SURVIVAL; STRATEGIES; ETOPOSIDE;
D O I：
10.1007/s12032-009-9340-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The aim of this study was to evaluate the efficacy and toxicity of docetaxel (TAX), cisplatin (CDDP), and fluorouracil (5-FU) plus leucovorin (CF) as the neoadjuvant chemotherapy (NACT) regimens in the treatment of nonresectable advanced gastric cancer. Twelve patients with nonresectable advanced gastric cancer were treated with NACT regimens consisted of docetaxel, cisplatin, fluorouracil, plus leucovorin before operation. Nine of the 12 patients were downstaged and 8 were radically operated after the end of the NACT. The overall response rate was 75% with 8.3% complete response and 66.7% partial response, and the ascites disappeared in 63.6%. The most common toxicities were bone marrow suppression, nausea, vomiting, alopecia, and heptoses. The toxicities were recoverable after symptomatic treatment. The results confirmed that the combination of docetaxel, cisplatin, fluorouracil plus leucovorin (CF) is a very effective and well-tolerated regimen as NACT for the patients with nonresectable advanced gastric cancer.
引用
收藏
页码：1089 / 1095
页数：7
相关论文
共 50 条
[41]   Neoadjuvant chemotherapy with a combination of irinotecan and cisplatin in advanced gastric cancer - A case report [J].
Yoshikawa, T ;
Tsuburaya, A ;
Kobayashi, O ;
Sairenji, M ;
Motohashi, H ;
Kameda, Y ;
Noguchi, Y .
HEPATO-GASTROENTEROLOGY, 2000, 47 (36) :1575-1578
[42]   Effectiveness of neoadjuvant chemotherapy with a docetaxel, cisplatin, and S-1 (DCS) regimen for T4b gastric cancer [J].
Long, Vo Duy ;
Thong, Dang Quang ;
Dat, Tran Quang ;
Nguyen, Doan Thuy ;
Phuoc, Tran Duy ;
Hai, Nguyen Viet ;
Vuong, Nguyen Lam ;
Trung, Lam Quoc ;
Bac, Nguyen Hoang .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
[43]   PHASE-II STUDY OF THE ETOPOSIDE, LEUCOVORIN AND FLUOROURACIL COMBINATION FOR PATIENTS WITH ADVANCED GASTRIC-CANCER UNSUITABLE FOR AGGRESSIVE CHEMOTHERAPY [J].
DIBARTOLOMEO, M ;
BAJETTA, E ;
DEBRAUD, F ;
BOCHICCHIO, AM ;
GEBBIA, V ;
BOZZETTI, F ;
DOCI, R ;
BONFANTI, G ;
COZZAGLIO, L .
ONCOLOGY, 1995, 52 (01) :41-44
[44]   A Retrospective Study of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer [J].
Wang, Yajing ;
He, Kang ;
Zhou, Zhaofei ;
Zhong, Yuejiao ;
Li, Gang ;
Lu, Jianwei .
CANCER MANAGEMENT AND RESEARCH, 2020, 12 :8491-8496
[45]   Neoadjuvant chemotherapy for advanced gastric cancer: A meta-analysis [J].
Li, Wei ;
Qin, Jing ;
Sun, Yi-Hong ;
Liu, Tian-Shu .
WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (44) :5621-5628
[46]   Toxicity of Induction Chemotherapy with Docetaxel, Cisplatin and 5-Fluorouracil for Advanced Head and Neck Cancer [J].
Billan, Salem ;
Kaidar-Person, Orit ;
Atrash, Fadi ;
Doweck, Ilana ;
Haim, Nissim ;
Kuten, Abraham ;
Ronen, Ohad .
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2013, 15 (05) :231-235
[47]   Clinical study of cisplatin hyperthermic intraperitoneal perfusion chemotherapy in combination with docetaxel, 5-flourouracil and leucovorin intravenous chemotherapy for the treatment of advanced-stage gastric carcinoma [J].
Wu Zhibing ;
Deng Qinghua ;
Ma Shenglin ;
Zhang Ke ;
Wu Kan ;
Li Xiadong ;
Zhao Pengjun ;
Zheng Ruzhen .
HEPATO-GASTROENTEROLOGY, 2013, 60 (125) :989-994
[48]   Neoadjuvant Chemotherapy With Docetaxel-Cisplatin in Patients With Stage III N2 Non-Small-Cell Lung Cancer [J].
Liao, Wei-Yu ;
Chen, Jin-Hsin ;
Wu, Muzo ;
Shih, Jin-Yuan ;
Chen, Kuan-Yuh ;
Ho, Chao-Chi ;
Yang, James Chih-Hsin ;
Yu, Chong-Jen .
CLINICAL LUNG CANCER, 2013, 14 (04) :418-424
[49]   A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer [J].
Chen, LT ;
Liu, TW ;
Wu, CW ;
Chung, TR ;
Shiah, HS ;
Jan, CM ;
Liu, JM ;
Whang-Peng, J ;
Chang, JY .
ONCOLOGY, 2002, 63 (03) :239-247
[50]   Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: A Hellenic Cooperative Oncology Group phase II study [J].
Papakostas P. ;
Tsavdaridis D. ;
Kosmidis P. ;
Kalofonos H.P. ;
Sakantamis A. ;
Janinis D. ;
Skarlos D. ;
Bafaloukos D. ;
Bamias A. ;
Xiros N. ;
Fountzilas G. .
Gastric Cancer, 2006, 9 (1) :26-31
12345